Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Beeline Medicines
AddedJul 8, 2026
UpdatedJul 9, 2026
Beeline Medicines

Beeline Medicines

Series A

Clinical-stage biotechnology company developing precision therapies for autoimmune and inflammatory diseases.

HQ
Boston, MA, US
Founded
2025
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Beeline Medicines Corporation is a clinical-stage biotechnology company developing precision therapies for autoimmune and inflammatory diseases. The company's lead program, afimetoran, is an oral TLR7/8 inhibitor in development for lupus.

Beeline Medicines assembled an executive team with drug-discovery, clinical-development, and commercialization experience across multiple therapeutic areas. The company is advancing a portfolio of selective therapeutic candidates aimed at the underlying causes of immune-mediated diseases.

Beeline Medicines - Products & Services

  • afimetoran logo

    afimetoran

    An oral TLR7/8 inhibitor in development for lupus and autoimmune diseases.

Beeline Medicines - Similar Companies

Be Biopharma logo

Be Biopharma

HI-Bio logo

HI-Bio

hibio.com

IpiNovyx Bio logo

IpiNovyx Bio

Byomass logo

Byomass

byomasstx.com

Bayhill Therapeutics logo

Bayhill Therapeutics

AffaMed Therapeutics logo

AffaMed Therapeutics

affamed.com

Generate Biomedicines logo

Generate Biomedicines

Belhaven Biopharma logo

Belhaven Biopharma

belhavenbio.com

Outpost Medicine logo

Outpost Medicine

Treeline Biosciences logo

Treeline Biosciences

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Zabecor Pharmaceuticals logo

Zabecor Pharmaceuticals

Beryl Therapeutics logo

Beryl Therapeutics

Inipharm logo

Inipharm

inipharm.com

Beech Tree Labs logo

Beech Tree Labs

beechtreelabs.com

Beeline Medicines - Quick Facts

Who are Beeline Medicines' competitors?

Companies similar to Beeline Medicines include Be Biopharma, HI-Bio, IpiNovyx Bio and Byomass.

When was Beeline Medicines founded?

Beeline Medicines was founded in 2025.

Where is Beeline Medicines' headquarters located?

Beeline Medicines' headquarters is located in Boston, MA, US.

When was Beeline Medicines' last funding round?

Beeline Medicines' most recent funding round was for $426.3M (USD) in June 2026.

How much has Beeline Medicines raised to-date?

As of Jun 30, 2026, Beeline Medicines has raised a total of $426.3M (USD).

Beeline Medicines - Classification

Industry
  • Pharmaceuticals
Customer
  • Healthcare
Tags
  • Biotechnology